Edition:
United Kingdom

Cue Biopharma Inc (CUE.OQ)

CUE.OQ on NASDAQ Stock Exchange Capital Market

7.25USD
17 Jul 2019
Change (% chg)

-- (--)
Prev Close
$7.25
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
28,061
52-wk High
$12.00
52-wk Low
$4.16

About

Cue Biopharma Inc is a development-stage immunotherapy company. The Company is focused at developing biologics engineered to selectively modulate disease-relevant T cell subsets to treat cancer and autoimmune disease. Its Immuno-Oncology pipeline includes CUE-100 Framework, and CUE-200 Framework; and autoimmune pipeline includes... (more)
No analyst recommendations are available for .

Overall

No Ratios Available.

Financials

  CUE.OQ Industry Sector
P/E (TTM): -- 69.38 32.67
EPS (TTM): -- -- --
ROI: -- 8.96 14.49
ROE: -- 10.09 15.79

Earnings vs. Estimates